Citigroup’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,076
| Closed | -$23K | – | 5725 |
|
|
2022
Q1 | $23K | Buy |
+2,076
| New | +$23K | ﹤0.01% | 4351 |
|
|
2021
Q4 | – | Sell |
-295
| Closed | -$9K | – | 5241 |
|
|
2021
Q3 | $9K | Sell |
295
-2,666
| -90% | -$81.3K | ﹤0.01% | 4740 |
|
|
2021
Q2 | $137K | Buy |
2,961
+320
| +12% | +$14.8K | ﹤0.01% | 3739 |
|
|
2021
Q1 | $159K | Buy |
2,641
+338
| +15% | +$20.3K | ﹤0.01% | 3475 |
|
|
2020
Q4 | $121K | Buy |
2,303
+573
| +33% | +$30.1K | ﹤0.01% | 3555 |
|
|
2020
Q3 | $59K | Buy |
1,730
+49
| +3% | +$1.67K | ﹤0.01% | 3402 |
|
|
2020
Q2 | $146K | Sell |
1,681
-135
| -7% | -$11.7K | ﹤0.01% | 3240 |
|
|
2020
Q1 | $105K | Buy |
1,816
+28
| +2% | +$1.62K | ﹤0.01% | 3268 |
|
|
2019
Q4 | $129K | Buy |
1,788
+676
| +61% | +$48.8K | ﹤0.01% | 3378 |
|
|
2019
Q3 | $68K | Sell |
1,112
-390
| -26% | -$23.8K | ﹤0.01% | 3629 |
|
|
2019
Q2 | $143K | Buy |
1,502
+464
| +45% | +$44.2K | ﹤0.01% | 3404 |
|
|
2019
Q1 | $84K | Buy |
1,038
+379
| +58% | +$30.7K | ﹤0.01% | 3699 |
|
|
2018
Q4 | $107K | Buy |
659
+520
| +374% | +$84.4K | ﹤0.01% | 3455 |
|
|
2018
Q3 | $23K | Buy |
139
+66
| +90% | +$10.9K | ﹤0.01% | 4467 |
|
|
2018
Q2 | $11K | Buy |
+73
| New | +$11K | ﹤0.01% | 4586 |
|